Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature

scientific article published on 25 July 2008

Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/S12282-008-0063-Y
P698PubMed publication ID18654829

P50authorShigehira SajiQ88034326
Katsumasa KuroiQ114818696
P2860cites workHigh-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell linesQ35994568
P433issue4
P304page(s)262-269
P577publication date2008-07-25
P1433published inBreast CancerQ15752871
P1476titleApplication of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature
P478volume15

Reverse relations

cites work (P2860)
Q90122306Advances in Research on Anticancer Properties of Salidroside
Q37386840CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen
Q43072014Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene
Q37169705Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression
Q51549465Label-free sensing and atomic force spectroscopy for the characterization of protein-DNA and protein-protein interactions: application to estrogen receptors.

Search more.